Stepped Care Suicide Prevention for Youth
(STARRS-PC Trial)
Trial Summary
What is the purpose of this trial?
Suicide is the second leading cause of death among young people aged 12-17 years in the United States, yet many youth at risk for suicide are not identified or go untreated. Stepped care approaches have been shown to be effective at reducing suicide risk in clinical settings, including primary care. The goal of this hybrid I stepped wedge effectiveness-implementation study is to test the effectiveness of a population-based quality improvement (QI) intervention, entitled STARRS-PC (Stepped Approach to Reducing Risk of Suicide in Primary Care) compared to treatment as usual (TAU), in reducing the risk of suicidal behavior among youth in the pediatric primary care setting. STARRS-PC implements a clinical pathway for youth at elevated risk for suicide in pediatric primary care clinics. Clinical pathways are tools used by health professionals to guide evidence-informed practice. The STARRS-PC pathway consists of three evidence-based suicide clinical care processes: risk detection, assessment and triage, and, if needed, follow-up transitional care. STARRS-PC is guided by the Practical, Robust Implementation, and Sustainability Model (PRISM), which allows for the study of factors that influence effective implementation of the suicide prevention clinical pathway and is focused on scalability. The main questions the study aims to answer are: * Will STARRS-PC be more effective than TAU at reducing the rate of suicide attempt at 12 months post-baseline (primary outcome)? * Will STARRS-PC be more effective than TAU at reducing suicidal ideation and non-suicidal self-injury, and improving family satisfaction at 12 months post-baseline (secondary outcomes)? * What are the barriers and facilitators of effective implementation and sustainability of STARRS-PC?
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, it mentions that youth receiving medication for physical or psychiatric conditions can participate, so it seems likely you can continue your current medications.
What data supports the effectiveness of the treatment Stepped Approach to Reducing Risk of Suicide in Primary Care (STARRS-PC)?
Research shows that primary care is a key setting for identifying and managing suicide risk, and engaging primary care professionals in suicide prevention can be beneficial. Programs like SUPRANET have shown that training primary care professionals improves their ability to apply suicide prevention practices, suggesting that similar approaches in STARRS-PC could be effective.12345
Is the Stepped Care Suicide Prevention for Youth treatment safe for humans?
How is the Stepped Approach to Reducing Risk of Suicide in Primary Care (STARRS-PC) treatment different from other suicide prevention treatments?
STARRS-PC is unique because it uses a stepped care approach, which means it provides different levels of treatment intensity based on the individual's needs, starting with the least intensive and moving to more intensive options if necessary. This approach is tailored to be delivered in primary care settings, making it more accessible and integrated into regular healthcare visits, unlike some other treatments that may require specialized settings.19101112
Research Team
Jennifer Hughes, PhD, MPH
Principal Investigator
Abigail Wexner Research Institue at NCH
Cynthia Fontanella, PhD
Principal Investigator
Abigail Wexner Research Institute at NCH
Jeffrey Bridge, PhD
Principal Investigator
Abigail Wexner Research Institute at NCH
Alex Kemper, MD, MPH, MS
Principal Investigator
Abigail Wexner Research Institute at NCH
Eligibility Criteria
This trial is for young people aged 12-17 who are at risk of suicide and receive care at one of the participating primary care clinics. It includes those with or without mental health issues, as well as those with physical illnesses or on medication, provided they meet other study criteria.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
TAU (Treatment As Usual)
Participants receive usual and customary care, establishing baseline rates of suicide risk screening and detection
Intervention
Implementation of the STARRS-PC clinical pathway, including universal screening and risk assessment for suicide
Sustainability
Sites work on maintaining or improving gains made during the intervention phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Stepped Approach to Reducing Risk of Suicide in Primary Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cynthia Fontanella
Lead Sponsor
Holzer Gallipolis
Collaborator
Holzer Jackson
Collaborator
Holzer Athens
Collaborator
Eastglen Pediatrics
Collaborator
Signature Health Ashtabula
Collaborator
Signature Health Willoughby
Collaborator
Signature Health Painesville
Collaborator
AxessPointe - Arlington
Collaborator
Dayton Children's Hospital
Collaborator